Download 14th annual miami cancer meeting (mcm)

_____________
PRST STD
US Postage
PAID
Miami, FL
Permit No. 1429
Meetings, Events and Conference Coordinators, Inc.
P.O. Box 430376
Miami, FL 33243-0376
14TH ANNUAL MIAMI
CANCER MEETING (MCM):
“From Chemotherapy to Targeted Therapy,
Immunotherapy and Beyond!”
January 20-22, 2017
Conrad Hilton Hotel
Miami, Florida
14TH ANNUAL MIAMI CANCER MEETING (MCM):
“From Chemotherapy to Targeted Therapy, Immunotherapy and Beyond!”
January 20-22, 2017
Conrad Hilton Hotel
Miami, Florida
Program Directors
Luis E. Raez, M.D, FACP, FCCP
Chief of Hematology-Oncology &
Medical Director
Memorial Cancer Institute
Memorial Health Care System
Clinical Associate Professor of Medicine
Herbert Wertheim College of Medicine
Florida International University
Miami, Florida
Co-Sponsored by:
Florida Society of Clinical Oncology
Caio Max S. Rocha Lima, M.D.
Hematology and Oncology
Associate Cancer Center Director for
Translational Research
Gibbs Cancer Center & Research Institute
CMO Guardian Research Network
Spartanburg Healthcare System
Spartanburg, SC
Edgardo S. Santos Castillero, M.D., FACP
Medical Director of Cancer Research
Thoracic and Head and Neck Cancer Programs
Eugene & Christine Lynn Cancer Institute
Associate Professor of Clinical Biomedical
Science
Charles E. Schmidt College of Medicine
Florida Atlantic University
Boca Raton, FL
Educational Committee
Jumana Ashy, M.S, Pharm.D
Eileen Butler, RN, MSN. OCN, CPHON, BMTCN
Gerardo Colon-Otero, MD
Dina Dumercy, Pharm.D., BCOP
Primo Lara, M.D.
Jessica MacIntrye, ARNP, NP-C
Eduardo Sotomayor, MD
Sponsored by:
The Medical Educator Consortium
Educational Committee • Distinguished Faculty
Educational Committee
Jumana Ashy, M.S, Pharm.D
Eileen Butler, RN, MSN. OCN, CPHON, BMTCN
Gerardo Colon-Otero, MD
Dina Dumercy, Pharm.D., BCOP
Primo Lara, M.D.
Jessica MacIntrye, ARNP, NP-C
Eduardo Sotomayor, MD
Distinguished Faculty
Jaffer A. Ajani, M.D.
Professor, Department of Gastrointestinal (GI)
Medical Oncology,
Division of Cancer Medicine,
Professor, Department of Epidemiology,
Division of OVP, Cancer Prevention and
Population Sciences
The University of Texas MD Anderson Cancer
Center
Houston, TX
Scott J. Antonia, M.D., Ph.D.
Department Chair of the Thoracic Oncology
Department H. Lee Moffitt Cancer Center and
Research Institute, Tampa, Florida.
Professor of Oncologic Sciences
University of South Florida College of Medicine
Tampa, FL
Jumana Ashy, M.S, Pharm.D
Clinical Pharmacist
Pediatric Hematology-Oncology Clinic and
Infusion Center
University of Miami, Miller School of Medicine
Miami, FL
Denisse Bretel, MD
Medical Director,
GECO (Peruvian Oncology Research Group)
Lima, Peru
Eileen Bulter, RN, MSN. OCN, CPHON, BMTCN
University of Miami Miller School of Medicine
Miami, FL
Gerardo Colon-Otero, M.D.
Associate Professor of Medicine
Mayo Clinic College of Medicine
Mayo Clinic, Jacksonville, FL
Dina Dumercy, Pharm.D.,BCOP
Clinical Coordinator Oncology
Memorial Cancer Institute
Pharmacy Department
Memorial Healthcare System
Hollywood, FL
Barbara J. Gilitz, M.D.
Associate Professor of Medicine,
USC Keck School of Medicine
Los Angeles, CA
Sergio A. Giralt, M.D.
Chief, Adult Bone Marrow Transplant Service;
Melvin Berlin Family Chair in Multiple Myeloma
Memorial Sloan Kettering Cancer Center
New York, NY
Brian Hunis, M.D.
Caio Max S. Rocha Lima, M.D.
Hematology and Oncology
Associate Cancer Center Director for Translational
Research Gibbs Cancer Center & Research Institute
CMO Guardian Research Network
Spartanburg Healthcare System
Spartanburg, SC
Director of Head & Neck Cancer and Quality
Memorial Cancer Institute
Clinical Associate Professor of Medicine
Herbert Wertheim College of Medicine
Florida International University
Hollywood, FL
Head of Unit Phase I - Early Clinical Trials
Director of Clinical Trial Management Program
Oncology Department University Hospital
Antwerp, Belgium
Alan Koletsky, M.D.
Hope Rugo, M.D.
Affiliate Assistant Professor of Clinical Biomedical
Science
Charles E. Schmidt College of Medicine
Florida Atlantic University
Genitourinary Cancer Research Program
Lynn Cancer Institute
Boca Raton, FL
Christian Rolfo Cervetto, M.D., PhD
Professor of Medicine Director, Breast Oncology
and Clinical Trials Education University of California
San Francisco
Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
Edgardo S. Santos Castillero, M.D., FACP
Professor of Medicine, UC Davis School of Medicine
Acting Director, UC Davis Comprehensive Cancer
Center
Sacramento CA
Medical Director of Cancer Research
Lynn Cancer Institute
Thoracic and Head and Neck Cancer Programs
Associate Professor of Clinical Biomedical Sciences
Florida Atlantic University
Boca Raton, Florida
Jose Lutzky, M.D.
Eduardo Sotomayor, M.D.
Jessica MacIntyre, ARNP, NP-C
Martin S. Tallman M.D.
Eriberto Marques Jr., M.D.
Vicente Valero, M.D.
Primo N. Lara, Jr., M.D.
Co-Chief, Hematology & Oncology
Director, Mount Sinai Melanoma Program
Mount Sinai Medical Center
Miami, FL
Sylvester Comprehensive Cancer Center
University of Miami Miller School of Medicine
Miami, FL
Medical Director of Santa Agueda Hospital
Department of Medical Oncology
Member of SBOC/SLACOM
Recife-PE, Brazil
Taofeek K Owonikoko, M.D., Ph.D.
Director, Thoracic Oncology Program
Assistant Professor
Emory School of Medicine
Atlanta, GA
Luis E. Raez, M.D, FACP, FCCP
Chief of Hematology-Oncology &
Medical Director Memorial Cancer Institute
Memorial Health Care System
Clinical Associate Professor of Medicine
Herbert Wertheim College of Medicine
Florida International University
Miami, Florida
Director, George Washington University Cancer
Center Professor of Medicine, George Washington
University School of Medicine & Health Sciences
Washington, DC
Chief of Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, NY
Professor, and Deputy Chairman,
Breast Medical Oncology Department
Clinical Director, The Morgan Welch Inflammatory
Breast Cancer Research Program and Clinic
Associate Director, Nellie B. Connally Breast Center
The University of Texas M. D. Anderson Cancer
Center
Houston, TX
Adrienne M. Vazquez, MSN, ACNP-BC, AOCN
Memorial Sloan Kettering Cancer Center
New York, NY
13th Annual Miami Cancer Meeting (MCM): “New
Horizons in Treating Patients with Cancer: The Saga of Personalized Medicine”
CONFERENCE DESCRIPTION
(i.e., NSCLC, head and neck, prostate cancer, and others).
This is a three-day conference designed for medical
oncologists, hematologists, radiation oncologists, surgical
oncologists, physician assistants (PA), advanced registered
nurse practitioners (ARNP), oncology nurses, registered
pharmacists, pharmacy technicians, and radiation therapists.
General practitioners (internal medicine and family medicine)
will have the benefit of review standard of care and new
developments in cancer management. Residents in training
and fellows from these specialties are encouraged to attend.
4) Management of adverse events from the use of novel
immunotherapy and targeted therapy agents.
This year, a depth discussion in immunotherapy for
multiple tumor types will take place. Immunotherapy
in Oncology is changing the landscape of therapy for
different solid tumors such as lung cancer, bladder, kidney,
melanoma, and others. Also, topics in solid tumors and
hematological malignancies such as breast cancer, lung
cancer, gastrointestinal (GI) malignancies, genitourinary
(GU) cancers, gynecologic malignancies, head and neck
cancers, melanoma, multiple myeloma, CLL and nonHodgkin’s lymphoma, and myelodysplastic syndrome will
be reviewed. There will also be a special session devoted to
the area of supportive care in oncology, with emphasis on
bone metastasis, malignant hypercalcemia, and management
of chemotherapy, targeted therapy and immunotherapyrelated side effects. The areas of focus for this conference
will include the current standards of care in the treatment of
all aforementioned malignancies and new developments in
these areas of cancer care. There will be much emphasis on
molecular diagnosis and individualization of cancer therapy
based on molecular profiles. There will be reviews of new
chemotherapeutic agents, new antiangiogenic agents and
new immunotherapeutic agents.
Presentations from latest national (AACR 2016, ASCO 2016
and ASH 2016) and international forums (ESMO 2016 and
WCLC 2016) meetings will be discussed and guidelines of
cancer care will be emphasized. The participants in the
meeting will have the opportunity not only to learn, review,
and understand the state-of-the-art management in cancer
care but also engage in personal interaction with our panel
of experts in these subjects during our question and answer
sessions.
CONFERENCE OBJECTIVES
Upon completion of this course attendees will be able to:
1) Understand the latest advances in chemotherapy, targeted
therapy and immunotherapy options available for lung
cancer, breast cancer, GI malignancies, GU malignancies,
melanoma, brain tumors, head and neck cancer as well as
hematological malignancies including multiple myeloma,
NHL, MDS, and CLL.
2) Evaluate the current standards of care in the treatment of
a variety of solid and hematologic malignancies.
3) Discuss risks and benefits when combined modality of
treatment (that includes radiation therapy and surgery) is
delivered to patients who have localized malignant processes
5) Management of complications and symptoms induced by
chemotherapy, immunotherapy or targeted therapy including
nausea, vomiting, hematologic toxicities (e.g., anemia,
neutropenia) and others.
ACCREDITATION
The Medical Educator Consortium is accredited by the
Accreditation Council for Continuing Medical Education to
provide continuing medical education for physicians.
CREDIT HOURS (CME)
The Medical Educator Consortium, designates this live activity
for a maximum of 15.0 AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the
extent of their participation in the activity.
NURSING CEU
Continuing Education Credit for Nurses will be awarded by
the University of Miami Nursing Education Department. A
total of 15 CEU’s will be awarded for attendance to all three
days of the conference. Participants may attend separately
on Friday for 2.1 credit hours, Saturday for 8.4 credit hours,
and Sunday 4.5. A certificate of completion will be provided
to each participant at the end of the conference. Credit will
be entered into CE Broker.
PHARMACY CEU
This activity is approved for a total of 15 contact hours of
Continuing Education Credit for Pharmacists and Pharmacy
Technicians awarded by the University of Miami Sylvester
Comprehensive Cancer Center. Participants must attend all
day lectures to receive credit for that day. Partial credits are
not available. Where credits are approved on a sessionby-session basis, participants must attend each session in
its entirety to receive complete credit for the session.. A
certificate of completion will be provided to each participant
at the end of the conference. Credit will be entered into
CE Broker. UMHC/Sylvester is a approved by the Florida
Board of Pharmacy as a provider of continuing pharmacy
education. “Partial Credit are available”.
FACULTY DISCLOSURE STATEMENT
The Medical Educator Consortium (MEC) adheres to the
ACCME Standards for Commercial Support. All persons that
will be in a position to control the content of the CME Activity
are required to disclose all relevant financial relationships.
Faculty disclosure forms outlining this information will
be made available to all participants prior to educational
activity. MEC has also implemented a mechanism to identify
and resolve all conflicts of interest prior to the education
activity being delivered to learners. The source of all support
from commercial interests will also be disclosed to learners
prior to the beginning of the educational activity.
14th Annual Miami Cancer Meeting (MCM): “New
“From Chemotherapy to Targeted Therapy,
Immunotherapy and Beyond!”
PROGRAM AGENDA
Friday, January 20, 2017
:
5:00 pm – 7:30 pm
Registration & Visit Exhibits
5:30 pm – 5:40 pm
Welcome and Introduction
5:40 pm – 7:50 pm
Supportive Care and Palliative Therapy Session
Luis E. Raez
.
Moderator: Dina Dumercy
5:40 pm – 6:10 pm
Management of Immunotherapy-Induced Disorders
(pneumonitis, colitis, thyroid disorders, skin rash, and others).
6:10 pm – 6:40 pm
Cancer Therapy-Induced Bone Loss and Malignant Hypercalcemia.
Eriberto Marques, Jr.
6:40 pm – 7:10 pm
Nausea and Vomiting: Novel advances in Emesis Management.
Jessica MacIntyre
7:10 pm – 7:40 pm
Keynote Speaker: The Evolution of Lung Cancer Therapy in the
Last Decade: “From Chemotherapy to Targeted Therapy,
Immunotherapy and Beyond!”
Christian Rolfo
7:40 pm – 7:50 pm
Round Table Discussion and Q & A Session.
8:00 pm – 9:00 pm
Dinner & Learn Symposia (non CME)
Adrienne Vazquez
Speakers: MacIntyre, Vazquez,
Marques, and Rolfo.
Saturday, January 21, 2017
7:00 am – 6:00 pm
Registration & Visit Exhibits
7:40 am – 8:40 am
Breakfast & Learn Symposium (non CME)
8:40 am – 10:40 am
Immunotherapy Session 1
Malignant Diseases: The New Targets of Immunotherapy.
Moderator: Luis E. Raez
8:40 am – 9:20 am
Immunotherapy in Lung Cancer.
Scott Antonia
9:20 am – 10:00 am
Immunotherapy in Genitourinary Cancers.
Alan Koletsky
Immunotherapy in Melanoma.
Jose Lutzky
10:00 am – 10:40 am
10:40 am – 11:00 am
Coffee Break & Visit Exhibits
11:00 am – 1:00 am
Immunotherapy Session 2
Malignant Diseases: The New Targets of Immunotherapy.
Moderator: Brian Hunis
11:00 am – 11:40 pm
Immunotherapy in Head and Neck Cancer.
Edgardo S. Santos
11:40 am – 12:20 pm
Immunotherapy in Breast and Gynecologic Malignancies.
Gerardo Colon-Otero
12:20 pm – 12:50 pm
Is it PDL-1 the Biomarker? Mutation Burden? Or What is the
Best Biomarker for Lung Cancer Immunotherapy?
Taofek Owonikoko
12:50 pm – 1:00 pm
Round Table Discussion and Q & A Session.
1:00 pm – 2:00 pm
Lunch & Learn Symposia (non-CME)
2:00 pm – 2:20 pm
Coffee Break and Visit Exhibits
09:10 am –
Speakers: Santos, Colon-Otero,
Owonikoko and Hunis
PROGRAM AGENDA Continued...
2:20 pm – 4:00 pm
Genitourinary Malignancy Session
Moderator: Edgardo S. Santos
2:20 pm – 3:00 pm
Tyrosine Kinase Inhibitors and Other Pathways in
Renal Cell Carcinoma.
Primo N. Lara, Jr.
3:00 pm – 3:40 pm
Novel Pathways and Genomics in the Management
of Prostate Cancer.
Alan Koletsky
3:40 pm – 3:50 pm
Round Table Discussion and Q & A Session.
Speakers: Lara, Koletsky and Santos
3:50 pm – 4:00 pm
Coffee Break & Visit Exhibits
4:00 pm – 5:40 pm
Hematology Malignancies Session
Moderator: Eduardo M. Sotomayor
4:00: pm – 4:30 pm
Immunotherapy and Targeted Therapy in Multiple Myeloma.
Sergio Giralt
4:30 pm – 5:00 pm
Targeted Therapy for B- and T-Cell Non-Hodgkin’s Lymphomas.
Eduardo M. Sotomayor
5:00 pm – 5:30 pm
High Risk Myelodysplasia and Acute Leukemias.
Martin Tallman
5:30 pm – 6:00 pm
Round Table Discussion and Q & A Session.
Speakers: Giralt, Sotomayor, Tallman
Sunday, January 22, 2017
7:00 am – 3:10 am
Registration &Visit Exhibits
7:40 am – 8:40 am
Breakfast & Learn Symposia (non CME)
8:40 am – 9:50 am
Gastrointestinal Malignancy Session
Moderator: Caio Max Rocha-Lima
8:40 am – 9:10 am
Novel Advances in Treatment of Gastric Cancers and
Pancreatobiliary Malignancies.
Caio Max Rocha Lima
9:10 am – 9:40 am
Genomics and New Insights of Colorectal Cancer.
Jaffe Ajani
9:40 am – 9:50 am
Round Table Discussion and Q & A session
Speakers: Ajani and Rocha-Lima
9:50 am – 10:20 am
Thyroid Malignancies.
Brian Hunis
10:20 am – 10:40 am
Coffee Break & Visit Exhibits
10:40 am – 12:40 pm
Lung Cancer Session
Moderator: Edgardo S. Santos
10:40 am – 11:10 am
EGFR, ALK and ROS-1 in Lung Cancer.
Luis E. Raez
11:10 am – 11:40 am
Other Novel Pathways in Lung Cancer (MET, RET, NTRK, BRAF)
and Antiangiogenic Agents.
Barbara Gitlitz
11:40 am – 12:10 pm
Where are we now in Squamous-NSCLC and Small Cell Lung Cancer?
Edgardo S. Santos
12:10 pm – 12:30 pm
Round Table Discussion and Q & A Session.
Speakers: Gitlitz, Raez & Santos
12:30 pm – 1:40 pm
Lunch & Learn Symposia
1:40 pm – 3:15 pm
Breast Cancer Section
Moderator: Denisse Bretel
1:40 pm – 2:20 pm
Anti-HER2 Therapies in Breast Cancer: Adjuvant
and Neoadjuvant.
Hope Rugo
2:20 pm – 3:00 pm
Chemotherapy and Hormonal Therapy in the
Metastatic Setting. (non Her2 therapy)
Vicente Valero
3:00 pm – 3:10 pm
Round Table Discussion and Q & A Session.
Speakers: Rugo, Valero, and Bretel
3:10 pm
Meeting Adjourn and Closing Remarks
REGISTRATION
HOTEL INFORMATION
Fees: $250 - Physicians
$100 - Residents, Fellows,
Nurses & Allied
Health Professionals
$300 - Industry Professionals
The Conrad Hilton Hotel Miami
1395 Brickell Avenue
Miami, FL 33131
Telephone: 305-503-6585
Website: http://conradhotels1.hilton.com
Registration fee includes all day admission
to the Friday evening, Saturday, and Sunday
scientific presentations. Refunds must be
provided in writing prior to December 20th,
2016 no Refunds will be provided. Prior to
the December 20th deadline any cancellation will include a $50 administrative charge.
Register online at www.meccinc.com
Discover the luxury of the Conrad Miami, the premier hotel in South Florida, combining the ultimate hotel service and the latest technological advancements with
the fashion sensibilities of downtown Miami. Located in the innovatively designed
structure of concave glass and steel, in the heart of the city’s financial district,
the Conrad Miami hotel overlooks Biscayne Bay in Florida.The Conrad Miami has
quick and easy access to many attractions in downtown Miami, including South
Beach, Coconut Grove and Key Biscayne and is also just 15 minutes from the Miami International Airport.
Register online at www.meccinc.com
CONFERENCE MANAGEMENT MECC
(Meetings Events & Conference
Coordinators, Inc.)
6619 S Dixie Highway #341,
Miami, FL 33143
Telephone 305/663-1628
Office Fax 305/675-2718
The hotel is offering special rates during this conference of $315 Deluxe City
View; $345 Deluxe Bay View plus tax, European plan (no meals). The cut of date
to make reservations is January 4, 2017, after this date reservations are subject to
hotel availability.
Make your reservations by calling 1-800-CONRADS and identify you as attending
the “Miami Cancer Meeting” group code “AMC ” or using the link
https://resweb.passkey.com/go/MCM2017
Or visit our website at
www.meccinc.com
REGISTRATION FORM
14th Annual Miami Cancer Meeting (MCM):
“From Chemotherapy to Targeted Therapy, Immunotherapy and Beyond!”
January 20-22, 2017
Conrad Hilton Hotel, Miami, FL
Register online at www.meccinc.com or FAX to 305/675-2718.
Name __________________________________________________________________________ Degree __________________________
Address ___________________________________________________________________________________________________________
City _________________________________________________ State ______________________ Zip _____________________________
Telephone (_____)_____________________________________________ Fax (_____)__________________________________________
Email address _____________________________________________________________________________________________________
Specialty _________________________________________________________________________________________________________
Type of Practice:
o Private
o Academic
o Hospital
o Resident/Fellow
Registration fee:
$ 250 - Physicians
$ 100 - Residents, Fellows, Nurses and Allied Health Professionals
$ 300 - Industry Professionals
Enclosed is my check in the i/a/o of _____ for registration of this course.
I authorize MECC to charge my credit card i/a/o $______ for registration of this course using the following credit card.
Name on Card ________________________________________________________________ Exp. Date ___________________________
Card number _________________________________________________________________ CVV ________________________________
Authorized signer __________________________________________________________________________________________________
If you require special assistance or have specific dietary requirements, please contact MECC, Inc. no later than January 4th, 2017
via email at [email protected].